Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Leading No Fee Savings Accounts Rates highlight current top yields and terms for zero-fee savings. Compare rates and access across providers.
19,858 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
The Trade Desk has faced a tough stretch, but patient investors are asking if the trade desk stock finally offers a p...
Fermi’s stock jump today highlights how earnings, project milestones, and strategic pivots shape appetite for AI infr...
Bitcoin ETFs pulled about $2 billion in net inflows in April, the strongest monthly total so far this year. May opene...
As 2026’s stock-split wave unfolds, investors eye three high-profile names—AutoZone, Grainger, and United Rentals—for...
Regulators green-light a new type of BTC trading on Kalshi. Learn how the CFTC's approval of Bitcoin perpetual future...
Markets remain choppy as 2026 unfolds. This article lays out practical steps to shield portfolios and stay resilient ...
Kalshi launches LINKPERP, a CFTC-regulated Chainlink perpetual contract, coinciding with LINK ETF assets surpassing $...
June's trading floor is flashing mixed signals: a SpaceX-inspired rally taps telecom names, but EchoStar pulls back o...
SpaceX hit the public markets with an IPO price of $135 per share, signaling a game-changing moment for growth invest...
As Warren Buffett steps back, Berkshire Hathaway's portfolio is evolving. This guide breaks down how the post-Buffett...
June delivered a sharp pause as the Magnificent Seven shed trillions, signaling a shift toward chipmakers and AI infr...